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Introduction
Precursor cells that generate the various differentiated cell 
types of the central nervous system (CNS) are generally located 
in defi  ned areas of the developing embryo, which frequently 
correspond to the ventricular zones of the developing nervous 
system. During a large part of the development of the embryo, 
neural progenitors proliferate to renew the precursor pool and, 
in parallel, give rise to postmitotic cells that move out of the 
progenitor areas (Temple, 2001). The balance between the gen-
eration of precursor and postmitotic cells shifts during develop-
ment but has to be tightly controlled to guarantee the formation 
of the appropriate neuronal cell numbers and the size of the 
tissue domains. Nervous tissue in the vertebrate embryo arises 
through complex processes of neural induction of the ectoderm, 
the delineation of neurogenesis-competent domains within the 
neural plate, and differentiation of neural precursors within these 
regions (Harland, 2000; Bally-Cuif and Hammerschmidt, 2003; 
Hammerschmidt et al., 2003). Simultaneously, the expansion of 
each neuronal compartment takes place until its defi  nitive size 
and form are reached. At this point in time, the neurons undergo 
terminal differentiation, thereby acquiring the characteristics 
necessary for participation in nervous signal propagation while 
simultaneously losing their capacity for further proliferation.
As the mechanisms controlling the spatio-temporal timing 
of the sequence of proliferation and differentiation of neuronal-
committed cells are still only partly understood, we performed 
a differential display of mRNAs designed to isolate genes that 
are differently expressed during neuronal differentiation as well 
as genes responsible for the proliferation of the stem cell com-
partment in vivo.
Results
Identiﬁ  cation of d-Asb11 as a 
differentiation down-regulated gene
We used a differential display screen to discover genes that are 
involved in control of neural stem cell compartment   proliferation. 
To this end, zebrafi  sh embryos were either left untreated or 
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rom a differential display designed to isolate genes 
that are down-regulated upon differentiation of the 
central nervous system in Danio rerio embryos, we 
isolated d-asb11 (ankyrin repeat and suppressor of cyto-
kine signaling box–containing protein 11). Knockdown 
of the d-Asb11 protein altered the expression of neural 
precursor genes sox2 and sox3 and resulted in an initial 
relative increase in proneural cell numbers. This was re-
ﬂ  ected by neurogenin1 expansion followed by premature 
neuronal differentiation, as demonstrated by HuC label-
ing and resulting in reduced size of the deﬁ  nitive   neuronal 
compartment. Forced misexpression of d-asb11 was 
  capable of ectopically inducing sox2 while it diminished 
or entirely abolished neurogenesis. Overexpression of 
d-Asb11 in both a pluripotent and a neural-committed 
progenitor cell line resulted in the stimulus-induced inhi-
bition of terminal neuronal differentiation and enhanced 
proliferation. We conclude that d-Asb11 is a novel regu-
lator of the neuronal progenitor compartment size by 
maintaining the neural precursors in the proliferating un-
differentiated state possibly through the control of SoxB1 
transcription factors.
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were pulse treated with 0.5 μM all-trans retinoic acid (RA) 
between 50 and 60% epiboly when neural induction and pat-
terning are initiated. Subsequently, mRNA was isolated from 
wild-type and treated embryos at 90% epiboly, which, after 
conversion into cDNA, was used for a differential display us-
ing the transcripts from the untreated embryos as driver cDNA 
and the transcripts from the treated embryos as tester cDNA. 
The resulting differential fragments were tested using whole-
mount in situ hybridization at different developmental stages. 
One fragment was singled out for detailed characterization 
based on its restricted spatio-temporal expression pattern dur-
ing late gastrulation and early somitogenesis. Obtaining a full-
length sequence of the down-regulated fragment revealed that 
the gene was most homologous to mammalian ASB11 (ankyrin 
repeat and suppressor of cytokine signaling [SOCS] box–
  containing protein 11), thus identifying this gene as d-asb11 
(sequence is deposited at the National Center for Biotechnol-
ogy Information under GenBank/EMBL/DDBJ accession no. 
AJ510191; Fig. 1 A, supplemental material, and Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200601081/DC1). 
Expression of d-Asb11 suggests a role 
in the developing nervous system
ASB family members contain a relatively divergent N-terminal 
domain followed by a varying number of ankyrin repeats and 
a C-terminal SOCS box acting as a part of a ubiquitin ligase 
complex (Kile et al., 2002; Wilcox et al., 2004; Chung et al., 
2005; Heuze et al., 2005) and are expressed in members 
throughout the chordate phylum (Kile et al., 2000; Liu et al., 
2003; Guo et al., 2004). d-asb11 was not maternally expressed 
because the transcripts were not detected by in situ hybridiza-
tion or Northern blotting in 2.5 h postfertilization (hpf) em-
bryos (unpublished data). The expression of d-asb11 was by in 
situ hybridization fi  rst detected at 4 hpf and was ubiquitous 
throughout the blastoderm (Fig. 1 B), and such uniform ex-
pression was maintained until late gastrula, when d-asb11 tran-
scripts were restricted to the polster (Fig. 1 B). At the tailbud, 
neuroectodermal expression extends as two stripes along the 
margins of the neural plate (Fig. 1 C), most likely overlapping 
with the posterior lateral neural plate expression of notch 1b 
and the lateral neural plate expression of notch 3 (Figs. 2 and 3 
in Westin and Lardelli, 1997) and being complementary to pro-
neural domains expressing deltaA (Fig. 1 D). At the level of the 
prospective mid/hindbrain boundary, two bilateral domains of 
expression are detected (Fig. 1, C and E). The expression is 
transient, as this pattern is maintained until 12 somites. From 
12 somites to at least 3 d after fertilization, there was no ex-
pression detectable by in situ hybridization, although low lev-
els of mRNA were still detected in 24 hpf embryos by Northern 
blotting (unpublished data). In RA-treated embryos, the ex-
pression of d-asb11 is absent in the anterior half and down-
regulated in the posterior half of the embryo, which is consistent 
with its isolation as a down-regulated fragment from the dif-
ferential display screen (Fig. 1 E). Thus, the expression of 
d-asb11 may indicate its possible function in the spatio- temporal 
timing of proliferation and differentiation in the developing 
 nervous  system.
Knockdown of d-Asb11 causes premature 
neuronal commitment
Direct in vivo evidence for a role of d-asb11 in zebrafi  sh devel-
opment was obtained from d-Asb11 knockdown by the injec-
tion of morpholinos (MOs) designed to inactivate d-asb11 
(d-Asb11–MO; Nasevicius and Ekker, 2000). We generated an 
antibody against d-Asb11, tested it on transfected cells, and 
confi  rmed it by Western blotting of embryo extracts upon MO 
injection of zygotes, which resulted in embryos devoid of 
d-Asb11 protein (supplemental material and Fig. S2 C, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200601081/DC1). 
We assessed the effects of two different d-asb11 ATG MOs on 
development, and both gave similar phenotypes (see Materials 
Figure 1. Discovery, characterization, and expression of d-asb11. 
(A) Amino acid sequence of the d-Asb11 protein. The detection of a down-
regulated 0.34-kb fragment in RA-treated embryos in the differential dis-
play screen. (B) Expression of d-asb11 in zebraﬁ  sh embryos. (top) At 50% 
epiboly (5 hpf), d-asb11 transcripts are present throughout the blastoderm 
(animal pole up). (bottom) At 95% epiboly (9.5 hpf), d-asb11 transcripts 
are at a high level localized to the polster (p; lateral view, anterior up). 
(C) At the tailbud stage (10 hpf), the expression is strongest in the polster 
and along the margins of the neural plate. Weaker expression is present in 
two stripes extending toward the midline (asterisks) and in paraxial do-
mains (a compilation of images; dorsal view anterior to the top). (D) Dou-
ble label in situ hybridization at approximately three somites; d-asb11 is in 
blue, and deltaA is in red. The expression of deltaA in longitudinal proneu-
ronal domains is complemented by the expression of d-asb11 in the neural 
plate margins. (E) Asterisks mark regions of the prospective mid/hindbrain 
boundary. (left) Expression pattern of d-asb11 in zebraﬁ   sh embryos at 
90% epiboly. (right) Embryos treated with RA in which d-asb11 expression 
is absent in the anterior and diminished in the posterior part of the embryo 
(anterior to the left). The asterisks represent similar positions of the embryo. 
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and methods section MOs). At 3 d after fertilization, morphants 
were typically smaller with a shortened trunk, sometimes ac-
companied by a downward-directed curly tail and a hyperperi-
cardium (Fig. 2 A). Rescue experiments were performed in 
which d-Asb11 knockdown by MO that targets sequences up-
stream of ATG was rescued with the overexpression of myc tag 
(MT)–d-asb11 mRNA lacking these sequences. Based on the 
morphology, the overexpression of MT–d-asb11 (MO+) res-
cued 50% of the d-asb11 phenotype (MO), as shown by a de-
crease in phenotype from 50 to 25% (Fig. 2 A).
Next, d-Asb11 knockdown experiments were performed 
to determine changes in the expression of the proneural basic 
helix loop helix gene neurogenin1 (ngn1) that actively promotes 
neuronal differentiation, inhibits gliogenesis, and is also ex-
pressed in still-dividing neuronal precursors (Blader et al., 
1997; Morrison, 2001). Strikingly, d-Asb11 knockdown led to 
the expansion of ngn1 that was fi  rst observed at the three-somite 
stage, when in the morphants, ngn1 was expressed at a higher 
level and more contiguously in an otherwise unaffected pattern 
(Fig. 2 C). In the neural tube of d-asb11 morphants, lateral and 
dorsal expression domains of ngn1 were substantially expanded, 
as assessed by image quantifi  cation of the ngn1-positive surface 
in transversal sections of representative embryos (Fig. 2 B). 
Furthermore, strong ectopic ngn1 expression appeared at the 
center of the neural tube in the proliferative zone (Fig. 2 B). 
These data show that knockdown of d-Asb11 results in a prema-
ture commitment to the neuronal cell lineage.
d-Asb11 knockdown leads to premature 
postmitotic neuronal differentiation 
and reduced compartment size
Next, we investigated whether the inhibition of d-asb11 transla-
tion affects the generation of terminally differentiated neurons 
by analyzing the expression of huC, a marker for postmitotic 
neurons. Again at the three-somite stage, huC expression was 
increased in the morphants (Fig. 2 E) as compared with em-
bryos injected with inverted MO. A comparable, albeit more 
subtle, phenotype was obtained by labeling of a subpopulation 
of the primary neurons by islet1. As in morphants, islet1 neu-
rons were slightly more numerous with what appeared to be 
higher levels of transcript than in the controls (Fig. 2 D). The 
increase of HuC-positive cells in the neural tube as evaluated by 
antibody to HuC protein is maintained at 24, 48, and 72 hpf 
(Fig. 3, A and B). The proportion of HuC+ cells in the neural 
tube was at all times higher in morphants as compared with 
wild-type embryos and, at 72 hpf, occupied even most of the 
ventricular zone known to consist of the proliferating cells (Fig. 3, 
A and B). However, low numbers of HuC-negative cells were 
at 72 hpf still present in the ventricular zone, suggesting that the 
proliferating compartment was not entirely depleted by loss of 
function d-Asb11.
To quantify the proportion of postmitotic neurons relative 
to presumably proliferating unlabeled precursors that reside in 
the ventricular zone of the CNS, a 3D reconstruction of serial 
sections from a 24 hpf wild-type embryo and a representative 
Figure 2. Modulation of the neural precursor 
  compartment upon knockdown of d-Asb11. (A) Phe-
notypes of a wild-type (WT), d-Asb11 morpholino 
(MO)-injected, and inverted MO (INV)-injected em-
bryo at 3 d after fertilization. (right) Rescue of d-asb11 
MO-injected embryos with MT–d-asb11 mRNA (see 
Materials and methods). NI, not injected; MO, MO-
injected embryos; MO+, MO and MT–d-asb11–
injected embryos. The percentage of altered phenotype 
was scored for the different groups, and the data 
shown are representative of four independent experi-
ments. (B) The level and surface of ngn1 expression 
in the neural tube of 20 hpf embryos were enhanced 
in morphants (MO) as compared with the control 
(  embryos injected with inverted MO), and quantiﬁ  ca-
tion of ngn1 induction shows its signiﬁ  cant increase 
in the morphants (n = 5). (C and E) Increase in ngn1 
(C) and huC (E) mRNA-expressing cells in the d-asb11 
morphant. Left, control embryos; middle, morphant at 
approximately three somites; right, magniﬁ  cation  of 
wild-type and MO regional expression of ngn1 (C) 
and huC (E). (far right) Quantiﬁ  cation of the amount 
of staining to calculate the amount of stained cells 
(C, n = 5; E, n = 6). (A–C) The asterisks mark signiﬁ  -
cant differences using a chi-squared test (P < 0.05). 
Error bars represent SEM. (D) Increase in islet1 pri-
mary neurons in the morphants at the approximately 
ﬁ   ve-somite stage (right) as compared with embryos 
injected with inverted MO (for photography improve-
ment, polster was removed from the specimens). Bar 
(A), 200 μm; (B) 20 μm; (C–E) 100 μm; (C and E, 
right) 20 μm.JCB • VOLUME 174 • NUMBER 4 • 2006  584
24 hpf morphant was made (Verbeek and Boon, 2002). The 
measurements show that HuC+ cells contribute to 28% of the 
total volume of the neural tube in the wild-type embryo and 
36% in the morphant, confi  rming that the proportion of post-
mitotic neurons is increased in the morphant embryo (Fig. 3, 
A and B). These data suggest that the targeted knockdown of 
d-Asb11 results in premature postmitotic neuronal commitment 
of a subpopulation of neural precursors.
Knockdown of d-Asb11 impairs cell division 
in the developing nervous system
At 24 hpf, the expanded ngn1 compartment in the morphants 
could hold both terminally differentiated neurons as well as 
still-dividing ngn1+ precursors. To verify whether the HuC+ 
cells were indeed nondividing terminally differentiated neu-
rons, we performed double fl  uorescent whole-mount antibody 
labeling with HuC and a mitotic marker anti–phosphohistone-3 
(PH3) antibody. Examination of nine morphants and seven 
wild-type embryos revealed that there was no colocalization of the 
HuC+ and PH3+ signals (see Whole-mount immunolabeling). 
The data show that the knockdown of d-Asb11 resulted in 
a   relative and premature increase of terminally differentiated 
nondividing neurons already at 24 hpf (Fig. 3 C). It is very well 
possible that a fraction of the supernumerary ngn1+ cells in the 
morphants was still proliferating and, therefore, was not ex-
pressing HuC. The comparison of numbers of mitotic PH3+ 
cells between morphants and controls at 24 hpf showed that in 
the morphants, there was a slight but signifi  cant (P < 0.03) in-
crease in proliferation that was most likely caused by ectopic 
proliferating ngn1+ neurons (Fig. 3 E). These data suggest that 
d-Asb11 functions to prevent neuronal commitment possibly by 
sustaining proliferation. The reduction of the defi  nitive neuro-
nal compartment may be the result of the depletion of neural 
progenitors through decline in proliferation. This is supported 
by a highly signifi  cant (P = 0.008) decrease in PH3+ mitotic 
cells at 48 hpf (Fig. 3, D and E).
Effects of d-Asb11 on compartment size 
through apoptosis
Concurrent to the decrease in proliferation, the apoptosis of pre-
maturely committed precursors could also contribute to a reduc-
tion in compartment size. To study this possibility, we analyzed 
whether the increase of HuC+ cells in the morphants was ac-
companied by apoptosis in the neural tube. We found slightly 
enhanced apoptosis at 24 hpf morphants using acridine orange 
as an indicator of apoptosis (Fig. 3 F). Analysis of apoptotic 
cells was extended using TUNEL assay (Fig. 3 F). Transversal 
sections of the neural tube of wild-type embryos showed apop-
totic Rohon-Beard neurons, whereas throughout the entire neu-
ral tube of the morphants, there was an increase in apoptosis 
(Fig. 3 F). This suggests that cell survival of the prematurely 
committed neuronal precursors may be compromised as a con-
sequence of d-Asb11 knockdown.
Effects of d-Asb11 knockdown on neuronal 
development are upstream of the SoxB1 
HMG group of transcription factors
Because d-Asb11 appears to function in preventing neuronal 
commitment of the progenitors, we studied whether knock-
down of d-Asb11 altered the expression of neural progenitor 
Figure 3.  Modulation of differentiation, prolifera-
tion, or apoptosis in the neural tube upon the knock-
down of d-Asb11. (A) HuC antibody labeling of 
postmitotic neurons in the spinal cord at 24, 48, and 
72 hpf embryos of wild type (WT) and morphants 
(MO). (B) 3D reconstruction of a representative HuC-
labeled 24 hpf morphant and wild-type embryo to cal-
culate the proportion of postmitotic neurons (red, 
HuC-positive neurons; green, unlabeled cells; yellow, 
notochord). (C–E) Double immunoﬂ  uorescence label-
ing of a mitotic cell with anti-PH3 antibody (green) 
and terminally differentiated neurons with anti-HuC 
antibody (red) at 24 (C) and 48 hpf (D) in morphants 
and wild-type neural tubes (anterior to the left) show-
ing a transient, slight increase in proliferation at 24 
hpf followed by a strong decrease in proliferation by 
48 hpf and relative increase of HuC+ neurons (red). 
(E) Quantiﬁ   cation of PH3+ mitotic cells. Error bars 
represent SEM. *, P < 0.05; **, P < 0.005. (F, left) 
Acridine orange staining at 24 hpf showing enhanced 
apoptosis in the neural tube of morphants (arrowhead) 
and few apoptotic cells in wild-type embryos (lateral 
view, rostral to the left). (right) TUNEL assay shows in-
creased apoptosis (blue cells) throughout in the neural 
tube of 24 hpf morphants versus only Rohon-Beard 
apoptosis in the dorsal-most neural tube of the control 
embryo. Transverse sections through the neural tube 
are shown. Bars (A), 20 μm; (B–D) 100 μm; (F, left) 
200 μm; (F, right) 20 μm.ASB11 REGULATES NEURAL PROGENITOR COMPARTMENT SIZE • DIKS ET AL. 585
genes sox2 or sox3 of the SoxB1 high mobility group (HMG) 
box transcription factors. The expression of sox2 and sox3 
through evolution correlates directly with ectodermal cells 
that are competent to acquire neural fate and subsequently 
may correlate with the commitment of cells to a neuronal fate 
(Pevny and Placzek, 2005; Wegner and Stolt, 2005). The ex-
pression of sox2 and sox3 in the zebrafi  sh developing CNS is 
found in the regions containing neural precursors as well as 
those containing neurons (Okuda et al., 2006). The situation 
is complex, as neither sox2 nor sox3 is uniformly expressed in 
all neural-competent cells of the neural plate. This is because 
there are other SoxB1 genes expressed in the developing CNS 
of zebrafi  sh and because the kinetics of expression during the 
transition between the neural precursor and neuron has thus far 
not been elucidated.
Strikingly, the knockdown of d-Asb11 affected the ex-
pression of both sox2 and sox3, albeit differently. At 20 hpf, 
sox3 expression in the neural tube was reduced in 50% of the 
morphants (Fig. 4 B), suggesting that d-Asb11 may function to 
maintain specifi  c levels of sox3 transcripts that may be required 
for precursor cell maintenance. If this is the case, d-Asb11 does 
so, most likely, in conjunction with other factors because the 
expression of sox3 was weaker but still present. This difference 
in the intensity of sox3 expression between morphants and con-
trols is already clear in whole-mount in situ hybridizations 
(Fig. 4 B). At 20 hpf in the neural tube of controls, sox2 tran-
scripts were cellularly condensed and appeared to be localized 
in specifi  c compartments of the cell (Fig. 4 A). In contrast, in 
40% of the morphants, sox2 transcripts were diffuse and ap-
peared scattered evenly throughout the cell (Fig. 4 A). The data 
suggest that d-Asb11 may be required for subcellular condensa-
tion of sox2 transcripts. We speculate that such condensed tran-
scripts may be representative of a specifi  c localization, and, in 
this form, sox2 may be required for maintenance of the precur-
sor cell fate. Such a mechanism of segregating and subcellularly 
localizing molecular determinants in precursor cells through, for 
instance, interactions with the cytoskeleton has extensively been 
studied in neuroblast development in Drosophila melanogaster 
(Wang et al., 2005). These data show that the loss of d-Asb11 
may mediate the reduction of a population of neural precur-
sors through affecting neural competence factors of SoxB1 
HMG group   transcription factors.
Forced expression of d-Asb11 
maintains progenitor expansion 
and impairs neurogenesis
Confi  rmation for d-Asb11 function in vivo and the possibility of 
its involvement in the transition of neural precursor to neuron 
was obtained in experiments in which we investigated whether 
the misexpression of d-asb11 mRNA would interfere with pri-
mary neurogenesis by evaluating islet1 expression, a marker for 
primary neurons, as well as the expression of neuronal markers 
ngn1 and huC (Fig. 5, A and B). Indeed, in 70% of the embryos, 
islet1 expression was affected (Fig. 5 A). Most prominent was a 
reduction or total absence of islet1 expression in the lateral sen-
sory Rohon-Beard neurons. Occasionally, defects in the ventro-
medial motor neurons or the cranial ganglia were observed. 
Immunolabeling demonstrated that MT–d-Asb11 was present 
in the domains that did not contain islet1 labeling. Comparable 
results were obtained with ngn1 and huC (Fig. 5 B).
To verify whether aberrant patterning of the neural plate 
could underlie abnormalities in primary neurogenesis, we 
evaluated the expression of regional neural plate markers her5, 
pax2.1, and krox20 upon the misexpression of d-asb11. Next 
to the wild-type expression pattern, we observed a   reduction 
of marker gene expression in embryos (Fig. 5, C and D). Most 
interestingly, we observed embryos in which marker expres-
sion was indicative of a split or otherwise deformed neural 
plate (Fig. 5, C and D), suggesting that in regions misexpress-
ing MT–d-Asb11, neural plate formation was disrupted. To 
investigate whether the loss of islet1-positive neurons and/or 
abnormalities in her5, pax2.1, and krox20 expression were sec-
ondary to neural plate defects, we studied the effect of d-asb11 
misexpression on the expression of germ cell nuclear factor 
(GCNF) as a neural plate marker (Braat et al., 1999; Barreto 
et al., 2003). The regional overexpression of MT–d-Asb11 as 
detected by anti-MT antibody labeling at the three-somite stage 
overlapped with the region of the neural plate where GCNF 
was absent (Fig. 5 E). This suggests that d-Asb11 negatively 
interfered with the establishment of the neural plate and that the 
absence of islet1-, ngn1-, and huC-labeled neurons and aber-
rant her5, pax2.1, and krox20 expression are the consequence of 
this event. To exclude the possibility that the misexpression of 
d-asb11 mediates nonspecifi  c repression of gene expression, we 
evaluated several markers upon the misexpression of d-asb11. 
Interestingly, the expression of the Notch target gene her1 
was ectopically expanded in embryos misexpressing d-asb11 
Figure 4.  Effect of d-Asb11 knockdown and misexpression on Sox2 and 
Sox3 expression in embryos. (A and B) Altered mRNA expression of neural 
precursor genes sox2 and sox3 upon the knockdown of d-Asb11 in trans-
versal sections of neural tubes and whole-mount in situ hybridizations 
(insets) showing at 20 hpf the lower expression of sox3 in the morphants and 
diffuse as opposed to condensed (in the wild types) expression of sox2 in 
the morphants. (C) Double whole-mount in situ hybridization for sox2 and 
anti-MT antibody labeling showing that MT–d-Asb11 is present in the cells 
ectopically expressing sox2 (four-somite stage embryo; anterior to the left). 
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(Fig. 5 C), whereas the expression of ptc1 was unaffected (not 
depicted), ruling out the possibility that d-asb11 is a general 
transcriptional repressor.
Effects of d-Asb11 misexpression on 
neuronal development are upstream of the 
SoxB1 HMG group of transcription factors
The aforementioned experiments suggest that d-Asb11 may, 
when misexpressed, function to block neuralization through 
forced maintenance of the precursor cell fate. In support of this 
notion, the phenotype of d-Asb11 morphants is characterized 
by altered expression of neural competence factors sox2 and 
sox3. To establish whether d-Asb11 misexpression may mediate 
its effects in preventing neuronal differentiation through the 
 induction  of  sox2 expression, we misexpressed MT–d-asb11 
mRNA. As a result, we sporadically observed scarce ectopic 
sox2-positive (sox2+) cells (unpublished data). In an attempt to 
increase the ineffi  ciency of MT–d-asb11 mRNA misexpression, 
we microinjected MT–d-Aasb11 DNA in embryos. Although 
the frequency of ectopic induction of sox2+ cells ( 5%) re-
mained low, the ectopically induced cells were more numerous. 
The ectopic expression of sox2 coincided with MT–d-Asb11 
protein expression (Fig. 4 C). These data show that when mis-
expressed, d-Asb11 is capable of inducing the neural precursor 
gene sox2. sox2 is expressed in neural precursors as well as in 
neurons. As d-Asb11 misexpression inhibited neurogenesis 
(Fig. 5), we propose that through its positive regulation of the 
sox2 gene, d-Asb11 may maintain neural-competent cells in 
their precursor state. The low frequency of this ectopic induc-
tion suggests a requirement for other limiting factors in order 
for d-Asb11 to induce sox2. Alternatively, potential negative 
regulators of sox2 would have to be excluded from cells to 
 ectopically  express  sox2.
The SOCS box is required for defects 
upon the misexpression of d-Asb11
We obtained functional insight into the molecular mechanism 
by which d-Asb11 acts from experiments in which we investi-
gated the action of mutated versions of d-asb11 with a specifi  c 
deletion of the SOCS box (d-asb11–∆SOCS) or of the entire 
C-terminal part after the last ankyrin repeat (d-asb11–∆C) us-
ing as a read-out their effects on islet1 neurons or on neural 
plate patterning as revealed by her5. Importantly, both mutant 
molecules resulted in a marked decrease of an altered expres-
sion pattern of islet1 when injected into zebrafi  sh  embryos 
(Fig. 5 A). As we have already shown, the expression of her5 
at early somitogenesis was clearly affected by the misexpres-
sion of d-asb11, as in  50% of the embryos, one half of the 
V-shaped expression domain at the mid/hindbrain boundary 
was shifted laterally or was diminished (Fig. 5 C). Likewise, 
when d-asb11–∆C or d-asb11–∆SOCS mRNA was microin-
jected, the wild-type expression pattern of her5 was maintained 
Figure 5.  Misexpression of d-Asb11 causes altered expression of different 
markers. (A) Quantitative analysis of defects in islet1 expression upon the 
misexpression of MT–d-asb11, MT–d-asb11–∆C, or MT–d-asb11–∆SOCS. 
Data are pooled from four independent experiments, and the SEM (error 
bars) is shown. (right images) Repression of islet1 expression by the misex-
pression of d-asb11 mRNA. (top left) Wild-type (WT) islet1. (top right) Ab-
sence of Rohon-Beard neurons at the injected side. (middle) Absence of the 
primary motor neurons and displacement of the cranial ganglia. (bottom) 
Immunolabeling of MT–d-Asb11 in islet1-labeled injected embryos. Immuno-
labeling of MT–d-asb11–injected embryos with the anti-myc antibody 
(9E10) demonstrates that one half is positive for MT–d-Asb11 translation 
and corresponds to defects in islet1 labeling. (far right) Misexpression of 
d-asb11–∆C or d-asb11–∆SOCS mRNA induces signiﬁ  cantly fewer defects 
in islet1 expression. (B) Loss and abnormalities in ngn1- and huC-labeled 
neurons upon the misexpression of MT–d-asb11 mRNA. (C) Misexpression 
of MT–d-asb11 mRNA induces ectopic expression of her1 (middle) or a 
subtle defect in her1 expression (bottom) as compared with wild-type her1 
expression (top). (far right) Patterning of the neural plate in wild-type em-
bryos and embryos misexpressing MT–d-asb11 mRNA as revealed by the 
mid/hindbrain marker her5. Misexpression of d-asb11–∆C or d-asb11–
∆SOCS induces signiﬁ   cantly fewer defects. (D) A combination of mid/
hindbrain marker pax2.1 and krox20 marker for rhombomeres 3 and 5 
reveals the loss of expression in embryos overexpressing d-asb11 mRNA. 
(E, left) GCNF is in the wild-type embryos expressed in the entire neural 
plate (middle), whereas GCNF expression is absent in the areas where 
MT–d-Asb11 is misexpressed (right). Anterior to the top in A–C and to the 
left in D and E. Asterisks mark the injected side of the embryo (three- to 
ﬁ   ve-somite stage embryos). mRNA was injected into one of the two 
  blastomeres. Bars, 100 μm.ASB11 REGULATES NEURAL PROGENITOR COMPARTMENT SIZE • DIKS ET AL. 587
in a high percentage of embryos (Fig. 5 C). Thus, the SOCS box 
of d-Asb11 is required for its biological effects.
The SOCS box of d-Asb11 is a component 
of the ubiquitin ligase complex
As mentioned in the second paragraph of Results, SOCS boxes 
frequently act in ubiquitin ligase complexes, and because the 
SOCS box in d-Asb11 appears to play an important role dur-
ing embryogenesis, we determined whether the SOCS box in 
d-Asb11 is also able to function as an ubiquitin ligase. Indeed, 
the overexpression of d-Asb11 either in zebrafi  sh embryos or in 
HeLa cells led to the ubiquitination of a variety of cellular pro-
teins in a SOCS box–dependent fashion (Fig. 6, A and B), dem-
onstrating that d-Asb11 is capable of functionally participating 
in a ubiquitin ligase complex and again showing that d-Asb11 
is a member of the ASB family (Kamura et al., 1998; Chung 
et al., 2005; Heuze et al., 2005). Importantly, cells transfected 
with the control expression vector or with SOCS box–defi  cient 
d-Asb11 were incapable of ubiquitination (Fig. 6, A and B). 
Thus, d-Asb11 can act as an ubiquitin ligase in a SOCS box–
dependent fashion. Ankyrin repeats are important mediators 
of protein–protein interaction, and, thus, we reasoned that if 
d-Asb11 has the capacity to act as an ubiquitin ligase, it is most 
likely acting on ankyrin repeat–containing proteins. Indeed, 
we observed that upon coexpression in HeLa cells, d-Asb11 
  coimmunoprecipitates with various ankyrin repeat–  containing 
proteins, including I-κBα and Notch, but not recombining 
binding protein-Jκ, which does not contain ankyrin repeats 
(Fig. 6, C–E).
d-Asb11 overexpression prevents terminal 
neuronal differention in vitro
The loss and gain of function experiments in zebrafi  sh em-
bryos suggest that d-Asb11 acts as a molecule that supports the 
maintenance of neuronal precursors possibly by safeguarding 
the proper identity and expansion of the precursor stem cell 
compartment. This notion was further tested using a specifi  c 
neuronal progenitor cell line (PC12) and a pluripotent embry-
onic carcinoma cell line (Nt2-D1; Greene and Tischler, 1976; 
Andrews et al., 1984). Experiments on PC12 cells were per-
formed using an NGF-induced in vitro differentiation of PC12 
pheochromocytoma cells according to the standard protocols 
(Greene and Tischler, 1976; Vaudry et al., 2002). Upon NGF 
stimulation, the cells transfected with control DNA showed a 
decrease in proliferation, which was determined by MTT (3-[4,5-
dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tetrazolium bro  mide) 
activity, and the expression levels of proliferating cell nuclear 
antigen (PCNA) and neurites were formed (Fig. 7, A and B). 
Strikingly, when d-Asb11 was overexpressed in PC12 cells, 
the proliferation was sustained, and the amount of neurites 
Figure 6.  d-Asb11 acts as an ubiquitin ligase in vitro. (A) HeLa cells were transfected with either MT alone, MT–d-Asb11, or MT–d-Asb11–∆C in combina-
tion with HA-ubiquitin. Before stimulation, 10 μM of the proteasome inhibitor MG-132 was added, and cells were stimulated for 60 min with 10 ng/ml 
IL-1β. Equal amounts of protein were immunoprecipitated with anti–IκB-α antibody and subsequently analyzed for the presence of ubiquitinated proteins 
by immunoblotting with ubiquitin antibody. (B) HeLa cells were transfected with MT-Notch1a intracellular domain and either HA–d-Asb11 or HA–d-Asb11–∆C 
in combination with HA-ubiquitin. Before immunoprecipitation, 10 μM of the proteasome inhibitor MG-132 was added, and cells were further processed 
after 60 min. Equal amounts of protein were immunoprecipitated with anti-MT antibody and subsequently analyzed for the presence of ubiquitinated pro-
teins by immunoblotting with ubiquitin antibody. (C) d-Asb11 can bind to Notch intracellular domain in a SOCS box–independent manner. (D) HEK293 
cells were transfected with HA–d-Asb11 and/or IκB-α (middle and bottom). Equal amounts of cell lysates were immunoprecipitated with the anti-HA anti-
body and analyzed for IκB-α expression. ΙκB-α was detected in the precipitate of HA-tagged proteins (top). (E) Recombining binding protein-Jκ is not able 
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was   signifi  cantly reduced (Fig. 7, A and B). Importantly, 
PC12 cells overexpressing d-Asb11 appear to continue prolif-
erating upon NGF-induced differentiation, as they form over-
laying colonies in contrast to control cells that remained in a 
monolayer (Fig. 7 C). The lack of NGF-induced neurite ex-
tension in d-Asb11–expressing PC12 cells may be caused by 
the incapacity of these cells to initiate neuronal differentiation 
but, alternatively, may refl  ect a block further down in the ex-
ecution of the neuronal differentiation program. To distinguish 
between these possibilities, we investigated the expression of 
growth cone–  associated protein 43 (GAP-43), a marker already 
expressed in proliferating neuroblasts, and the neurofi  lament, 
a marker of terminally differentiated neurons (Kanazir et al., 
1996; Mani et al., 2001; Shen et al., 2002). As expected from 
the neurite extension experiments, transfection of MT–d-asb11 
into PC12 cells inhibited neurofi  lament expression as assayed 
either by immunoblotting (Fig. 7 D) or immunofl  uorescence 
(Fig. 7 C). Importantly, however, d-Asb11 enhanced the NGF-
dependent expression of GAP-43 (Fig. 7 D).
To examine the effects that d-Asb11 may have upon the 
differentiation of uncommitted pluripotent embryonic car-
cinoma cells (Andrews et al., 1984, 1994), we chose Nt2-D1 
cells that differentiate primarily into neurons upon RA treat-
ment (  Andrews, 1984). When d-Asb11 was overexpressed in 
the Nt2-D1 cell line, it inhibited the RA-induced differentiation 
into neurons, as shown by diminished neurofi  lament expression 
(Fig. 7 E). Importantly, as in PC12 cells, these cells were still 
mitotically active, as shown by increased PH3 expression, sug-
gesting that these pluripotent cells are also blocked in a phase 
before terminal neuronal differentiation. Thus, the overex-
pression of d-Asb11 in both PC12 and Nt2-D1 cells enhances 
proliferation of the committed neural precursor in spite of dif-
ferentiation stimuli. These in vitro data are therefore consistent 
with the inhibition of neurogenesis upon the misexpression of 
d-Asb11 in the embryo.
Discussion
We have shown that in the developing zebrafi  sh embryo, d-asb11 
is expressed in the neural plate margins and is complementary 
to and abutting the proneuronal zone, as defi  ned by deltaA 
  staining. Before early somitogenesis, d-asb11 is ubiquitously 
expressed in the pluripotent cells of the blastoderm (Fig. 1 B). 
Progressive restriction of d-asb11 to the lateral regions of the 
neural plate as well as its transient expression at that location 
suggests that d-Asb11 may indeed support the stem cell fate.
Upon the knockdown or misexpression of d-asb11, the 
size of the terminally differentiated neuronal compartment in-
creases or decreases, respectively, suggesting that d-Asb11 is 
involved in regulation of the number of neurons that eventually 
arise. The relatively subtle minor initial increase in neurogene-
sis upon d-Asb11 knockdown, as not all dorsal or lateral precur-
sors are induced to differentiate, may implicate redundancy 
with other ASB family members from this group (Fig. S1). 
  Alternatively, the strictly localized and transient expression of 
d-asb11 could affect only a small subset of neural precursors, 
thereby resulting in this subtle phenotype.
We propose that during zebrafi  sh development, d-Asb11 
maintains the undifferentiated neural-competent state of a sub-
population of cells in the neural plate until its expression is 
down-regulated by subsequent differentiation signals (e.g., RA; 
Sockanathan and Jessell, 1998). Because d-asb11 is only tran-
siently expressed from 4 hpf until the 12-somite stage, upon its 
disappearance, cells devoid of d-Asb11 would become sensitive 
to secondary inductive signals and would be able to pursue the 
appropriate neuronal cell fate. Interestingly, the timing of extin-
guishing d-asb11 mRNA expression at  12 somites roughly 
corresponds with the fi  nal round of DNA synthesis occurring be-
tween 9 and 16 hpf in motor neurons (Myers et al., 1986). As fi  rst 
secondary neurons are born  6 h after the fi  rst primary neurons, 
Figure 7.  Effect of d-Asb11 on differentiation in PC12 or Nt2-D1 cells. 
(A) Proliferation of PC12 cells upon NGF stimulation. Relative mitochon-
drial activity was measured (MTT assay), and PCNA expression levels 
were determined. The experiments were performed in duplicate, and the 
values shown are the means and SEM (error bars) of 11 different samples. 
(B) Neurite length was measured in at least 10 different ﬁ  elds of cells for 
each condition. **, P < 0.01. (C) Fluorescent double labeling of PC12 
cells transfected with MT or MT–d-Asb11. d-Asb11 inhibited neuroﬁ  lament 
(NF) expression and allowed continued cell proliferation as compared 
with MT-transfected cells. (D) The protein expression proﬁ  le of GAP-43 and 
neuroﬁ  lament of whole cell lysates in PC12 cells after NGF stimulation. 
(E) Expression of neuroﬁ  lament, PH3 (Ser10), and actin in Nt2-D1 cells 
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it may be that d-Asb11 functions to separate waves of primary 
and secondary neurogenesis by maintaining a pool of precursors 
to respond to inductive signals operating later in development.
The loss of function of d-Asb11 causes premature neu-
ronal commitment that is refl  ected in ectopic ngn1 expression 
and followed by a relative increase of HuC+ terminally dif-
ferentiated neurons. In parallel, a progressive loss of ventric-
ular zone cells occurs, resulting in reduction of the defi  nitive 
neuronal compartment. Importantly, d-Asb11 may mediate its 
effects through control of SoxB1 neural precursor genes, as 
the knockdown results in a reduced and aberrant expression of 
sox3 and sox2, respectively. Concurrently, when misexpressed, 
d-Asb11 prevents neuronal differentiation possibly through the 
induction of sox2 or yet another SoxB1-type factor. Both gain 
of function and loss of function of d-Asb11 phenotypes in ze-
brafi  sh are in agreement with experiments in the chick in which 
the overexpression of Sox2 and/or Sox3 also inhibits neuronal 
differentiation of neural progenitors, which then maintain their 
undifferentiated state and capacity to proliferate. In contrast, 
dominant-negative Sox2 and/or Sox3 in neural progenitors re-
sults in premature exit from the cell cycle, and neuronal differ-
entiation ensues (Bylund et al., 2003; Graham et al., 2003). Our
data are consistent with a model in which d-Asb11 supports 
the maintenance of a proliferative subpopulation of neural 
 precursors. We further propose that d-Asb11 may control this 
process through SoxB1 neural precursor genes.
Consistent with such a model, it has been proposed that 
SoxB1 genes play a role in maintaining neural progenitors in 
the cell cycle and regulate the timing of their exit from the cell 
cycle. The fi  ndings that the inhibition of SOX2 function in chick 
neural progenitors (Graham et al., 2003) and rat oligodendro-
cyte precursor cells (Kondo and Raff, 2004) leads to their pre-
mature exit from mitosis support this hypothesis and are in 
agreement with loss of function d-Asb11, as d-Asb11 knock-
down similarly leads to the reduction of mitotic cell numbers 
after 24 hpf.
The role of d-Asb11 in maintaining the proliferative state 
of precursors was also illustrated in in vitro differentiation 
  models. When d-Asb11 is overexpressed in a neural-committed 
progenitor or a pluripotent cell line, these cells are unable to 
execute the terminal neuronal differentiation program, as shown 
by the inhibition of neurofi  lament expression upon exposure to 
stimuli that cause neuronal differentiation. Consistently, the 
proliferation was not inhibited in these cells as it was in the con-
trols, indicating that d-Asb11 is able to block terminal neuronal 
differentiation and allow cells to proliferate. 
Because PC12 is already committed to neural crest fate, the 
overexpression of d-Asb11 cannot prevent the PC12 cell in ac-
tivating its neuronal differentiation program (enhanced GAP-43 
expression in d-Asb11–transfected cells), but it can hold these 
cells in a state of proliferating neuroblast precursors. Consistent 
with the proposed role of d-Asb11 in the maintenance of neural 
precursors, GAP-43 is reported to be expressed in proliferating 
neuroblasts, and its function has been implicated in the cell cy-
cle, differentiation, and, eventually, also cell survival (Kanazir 
et al., 1996; Mani et al., 2001; Shen et al., 2002). Importantly, 
PC12 cells overexpressing d-Asb11 appear to have a block in 
further execution of the neural differentiation program (as they 
have diminished neurites and lower neurofi  lament expression). 
Our data suggest that d-Asb11 acts to maintain cells in the 
neuroblast state independently of their primary status, being 
  either pluripotent (Nt2-D1) or neural progenitor (PC12) cells.
Consistently, the misexpression of XSox3 with XBF1 
promotes the proliferation of neuroectodermal cells in Xenopus 
laevis embryos (Hardcastle and Papalopulu, 2000). We specu-
late that the misexpression of d-Asb11 in zebrafi  sh embryos 
perhaps through the induction of sox2 or another SoxB1-type 
factor may similarly affect the fate of zebrafi  sh neuroectodermal 
cells, thereby abolishing neuronal differentiation. The in vitro 
data on Nt2-D1 and PC12 cells, a pluripotent and a   neuronal-
  committed cell line, respectively, also suggest that d-Asb11 
functions by maintaining the proliferative state of the neural 
precursors, thereby making them refractory to differentiation 
signals perhaps through regulating SoxB genes.
Our fi  ndings show that d-Asb11 functions as a regulator of 
progenitor cell maintenance. More specifi  cally, it keeps progeni-
tors in a less differentiated, more proliferative state. Although lit-
tle is known about the functions of ASB proteins, the fact that 
ASB5 (which is highly homologous to d-Asb11) has a role in ar-
teriogenesis strengthens the notion that this class of ASB proteins 
may have a role in cell fate decisions (Boengler et al., 2003).
Interestingly, a possible role for d-Asb11 in the develop-
ment of the brain has recently indirectly been uncovered by the 
experiments performed by Nielsen et al. (2005). They compared 
the genetic mutations between the human and chimpanzee ge-
nome, looking for genes with an unusually higher number of 
functional nucleotide changes between the two species, which 
would suggest a possible important role for such genes in the 
defi  nition of being a chimpanzee or a human. Most of these genes 
were involved in the immune and reproductive systems, but 
ASB11 was among the highly altered genes between the human 
and chimpanzee genome despite its generally very high level of 
conservation in the chordate phylum. It is of course tempting to 
suggest that the obvious size differences between human and 
chimpanzee brains are also a result of altered ASB11 function.
Materials and methods
Fish and embryos
Zebraﬁ  sh were kept at 27.5°C. Embryos were obtained by natural mat-
ings, cultured in embryo medium, and staged according to Kimmel et al. 
(1995; Westerﬁ  eld, 1994).
Cell cultures
HEK293, HeLa, Nt2-D1, and PC12 cells were maintained in DME contain-
ing 10% FCS. The culture medium was supplemented with 5 mM glutamine 
and antibiotics/antimitotics. Cells were incubated in a 5% CO2 humidiﬁ  ed 
incubator at 37°C.
Plasmid construction
pCS2+MT (MT; myc-tagged expression vector), pCS2+MT–d-Asb11 
(MT–d-Asb11), pCS2+MT–d-Asb11–∆C (MT–d-Asb11–∆C), and pMT2SM-
HA–d-Asb11 (HA-tagged expression vector; HA–d-Asb11) were constructed 
as follows: an expression vector containing d-asb11, the coding region, 
was cloned into the BamHI–XhoI sites of the pCS2+ expression vector. To 
obtain a myc-tagged version of d-asb11 (MT–d-asb11), the coding region 
was cloned into the NcoI–XhoI sites of pCS2+MT. An MT–d-asb11–∆C 
construct encoding a C-terminal deletion (aa 229–293) was generated by 
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errors by sequencing. For HA-tagged d-asb11 (HA–d-asb11), d-asb11–∆C 
(HA–d-asb11–∆C), and d-asb11–∆SOCS (HA–d-asb11–∆SOCS), the cod-
ing region was cloned into the XhoI–EcoRI sites of pMT2SM-HA, and the 
expression constructs were subsequently veriﬁ  ed by sequencing. To obtain 
a construct for RNA synthesis of asb-a to control mRNA injections of MT–
d-asb11 mRNA, the 1.6-kb asb-a cDNA was cloned into the BglII and XhoI 
sites of pT7TS+. A partial cDNA fragment of asb-a in pBluescript was used 
as a template to generate a riboprobe for in situ hybridizations.
mRNA synthesis, mRNA and DNA microinjections, and rescue of d-Asb11 
knockdown with the misexpression of MT–d-asb11 mRNA
Capped mRNAs were synthesized using the mMESSAGE mMACHINE kit 
(Ambion). In rescue experiments of d-Asb11, knockdown MT–d-asb11 
mRNA at concentrations ranging from 2.5 to 50 pg was injected in 1 nl 
at the yolk/blastoderm interface in the one-cell stage upon microinjec-
tion with d-asb11 MO in one-cell stage embryos such that MO-  injected 
only embryos were the control for embryos ﬁ  rst injected with the MO 
and then with d-asb11 mRNA. A chi-squared test was performed to de-
termine the statistical differences in percent morphology in MO and po-
tentially   rescued MO-injected embryos The rescue could be performed 
because the MO-1 sequence was complementary to the 5′ untrans-
lated sequences not incorporating the ATG translation start site. In the 
MT–d-asb11   construct, myc was fused directly to the ATG, thus lacking 
the MO-1 target sequences.
To misexpress wild-type or mutant versions of d-asb11 mRNA, 
  zebraﬁ  sh embryos were injected at the two-cell stage in one of the two 
blastomeres (300 pg mRNA), resulting in defects in the injected half of 
the embryo. To misexpress MT–d-asb11 DNA, 10 pg was microinjected 
into zygotes.
In situ hybridization
Whole-mount in situ hybridizations were performed according to Joore 
et al. (1994) and for sox2 were performed according to Cunliffe and 
  Casaccia-Bonneﬁ  l (2006). Double label whole-mount in situ hybridization 
was performed according to Hauptmann and Gerster (2000). For histolog-
ical analysis, upon in situ hybridization, embryos were overstained for 48 h, 
subsequently ﬁ  xed for 1 h in 4% PFA in phosphate buffer, dehydrated, 
  embedded in plastic, and sectioned. deltaA and huC probes were pro-
vided by B. Appel (Vanderbilt University, Nashville, TN). Probes for her1 
and  her5 were provided by L. Bally-Cuif (Institute of Developmental 
  Genetics, Neuherberg, Germany). U. Strahle (Institute of Toxicology and 
Genetics, Forschungszentrum Karlsruhe, Karlsruhe, Germany) provided the 
probes for ngn1 and islet1. V. Cunliffe (Centre for Developmental Ge-
netics, University of Shefﬁ  eld, Shefﬁ  eld, United Kingdom) and S. Wilson 
(University College London, London, United Kingdom) provided the sox2 
and sox3 probes, respectively.
Acridine orange staining
Acridine orange staining was performed as described previously (Furutani-
Seiki et al., 1996) with modiﬁ  cation of the acridine orange (Sigma-Aldrich) 
solution (0.078 μg/ml in embryo medium).
TUNEL assay
TUNEL assay was performed as described previously by Cole and Ross 
(2001) with modiﬁ   cation of the staining reaction. Antidigoxigenin anti-
body was preabsorbed in blocking buffer (1% DMSO and 2% BSA in PBS) 
for 1 h at 4°C. Embryos were incubated overnight in blocking buffer with 
1:2,000 antidigoxigenin antibody at 4°C, washed eight times with PBS, 
and stained according to the method used for in situ hybridization.
cDNA library screen
A random primed λZAP neurula cDNA library prepared from 3 to 15 hpf 
embryos was used to screen 1.5 × 10
6 phages to obtain a full-length 
clone. The probe was labeled to high speciﬁ  c activity with α-[
32P]dCTP (GE 
Healthcare) using a Rediprime labeling kit (GE Healthcare). After in vivo 
excision, the longest positive clone was subcloned and sequenced.
MOs
Antisense MOs (Gene Tools, LLC) were designed to complement the 5′ un-
translated sequences of d-asb11 (d-asb11–MO-1; 5′-AGAAACCTCG-
CAGACAGCAACGGTC-3′) or sequences upstream and including the 
ATG start site (d-asb11–MO-2; 5′-CCATCTCTAAACTAAAACACAGCCA-3′), 
and, as a control, an inverted MO (d-asb11–MO; 5′-CTGGCAACGA-
CAGACGCTCCAAGA-3′) was used. Approximately 9 ng/1 nl was 
injected into one-cell stage embryos, whereas as a control, we injected 
 15 ng/1 nl of inverted MO.
Whole-mount immunolabeling
For whole-mount immunohistochemistry, ﬁ   xed embryos were rinsed in 
PBS and incubated in blocking solution for 1 h (PBS + 0.1% Tween 20 
containing 1% BSA and 2% normal lamb serum). The primary antibody 
(anti-HuC; Sigma-Aldrich) was added, and embryos were incubated 
overnight at 4°C. After washing in PBS + 0.1% Tween 20, embryos were 
incubated overnight at 4°C in goat anti–mouse peroxidase-conjugated 
secondary antibody. After extensive washing, embryos were incubated 
in 0.5 mg/ml DAB and reacted in 0.003% H2O2. For the double ﬂ  uores-
cent whole-mount antibody staining with anti-HuC and anti-PH3 antibody 
(Upstate Biotechnology), ﬁ  xed embryos were permeabilized for 4 min in 
2.5 mg/ml ice-cold trypsin in PBT (PBS + 0.1% BSA + 0.1% Tween 20; 
Worthington Biochemical Corp.) on ice, subsequently washed three times 
for 5 min each in PBT, and incubated for at least 1 h in blocking buffer 
(2% lamb serum, 0.1% BSA, 0.1% DMSO, and 1% Triton X-100 in PBS). 
To detect HuC and PH3, respectively, secondary antibodies were Cy3 
and Cy5 conjugated. Immunoﬂ   uorescently labeled embryos were 
  analyzed in 100% glycerol using confocal laser scanning microscopy at 
ambient temperature.
Analysis of confocal images
Potential cellular colocalization of HuC and PH3 signal in double im-
munoﬂ   uorescence experiments was analyzed using Volocity 3 software 
(  Improvision). To this end, all 50 optical z slices per embryo were scored 
(in total seven wild type and nine morphants at 24 hpf and seven wild 
types and eight morphants at 48 hpf).
To determine numbers of PH3-positive cells, they were scored manu-
ally on the cumulative z series for each embryo (for n see Results). The cells 
were counted at 30,000× magniﬁ  cation in a standardized square of 7-cm 
length and depth covering the extent of the neural tube deﬁ  ned by HuC 
  antibody labeling. Comparable regions were chosen in morphants and 
wild types with reference to the yolk-tube extension.
3D reconstruction and calculation
Volumes were calculated from a 3D reconstruction from 7-μm serial sec-
tions with an acquisition station (Verbeek and Boon, 2002). This resulted 
in 123 section images for the control and 149 section images for the 
treated ﬁ  sh. The notochord and otic vesicle were included to have a frame 
of reference.
Microscopy and image quantiﬁ  cation
Pictures were obtained using a microscope (Axioplan; Carl Zeiss 
  MicroImaging, Inc.) with a 10× NA 0.30 plan Neoﬂ  uar or a 40× NA 
0.65 Achroplan lens on a Leica microscope (TCS NT). Images were 
digitized with a camera (DFC480; Leica) and processed with the 
IM500 Image Manager (Leica). A stereomicroscope (MZ FLIII; Leica) 
with a camera (DC 300F; Leica) was used for Figs. 2 A and 7 B. Digi-
tal pictures of transversal sections of ngn1 in situ hybridizations were 
then quantiﬁ  ed with Image Analysis software (EFM Software) by calcu-
lating the total signal intensity. The pictures of sections were corrected 
from embryo size by dividing the amount of staining by the size of the 
embryo surface.
Digital pictures of whole-mount in situ hybridizations were obtained 
using a digital camera (DXM1200; Nikon). Some in situ images were used 
to determine the size of the stained compartments by counting the amount 
of positive pixels on the embryo and dividing this by the total size of the 
whole embryo. This number represents the relative size of positive cells in 
the whole embryo. All images were only adjusted for brightness, contrast, 
or color balance (autoequalize option).
MTT assay
PC12 cells were transfected with MT alone or MT–d-Asb11 plus neomycin 
resistance plasmid (see supplemental material for plasmid construction). 
After 5 d, polyclonal neomycin-resistant PC12 cells were reseeded in 
96-well plates and stimulated with 100 ng/ml NGF-2.5S (Invitrogen). After 
3 or 6 d, 0.1 mg MTT (M5655; Sigma-Aldrich) was added to the medium. 
The cells were lysed by the addition of 50 μl MTT lysis buffer (20% SDS 
and 10% dimethylformamide) to the medium, and absorbance was mea-
sured at 570 nm. The results are the mean and standard error of 11 inde-
pendent cultures obtained in two different experiments.
Measurement of the neurite length
The mean neurite length in Fig. 7 B was measured by blinded counting 
of the total amount of neurites divided by the amount of counted cells 
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Western blotting and immunoﬂ  uorescence
PC12 cells were transfected with MT alone or MT–d-Asb11 plus a neomycin 
resistance plasmid. After 5 d, the polyclonal neomycin-resistant PC12 cells 
were reseeded in six-well plates for neuroﬁ  lament and GAP-43 expression 
and on glass coverslips for immunoﬂ  uorescence. Cells were subsequently 
stimulated with 100 ng/ml NGF-2.5S (Invitrogen). After stimulation, the 
cells were lysed in cell lysis buffer (Cell Signaling) supplemented with phos-
phatase and protease inhibitors or ﬁ  xed in 4% PFA for 15 min and kept 
in PBS at 4°C.
Nt2-D1 cells were seeded in a 24-well plate 1 d before transfection 
using the MATra and IBAFect (IBA GmbH) transfection technique according 
to the standard supplier’s protocol. After 24 h, the medium was refreshed 
and 10
−6 M RA was added, and, after 48 h, the cells were lysed (Cell Sig-
naling) and supplemented with phosphatase and protease inhibitors.
After cell lysis, the samples were loaded on SDS-polyacrylamide 
gels. The material was transferred to Immobilon (Millipore) by wet blotting 
in transfer buffer (50 mM Tris, pH 8.0, 40 mM glycine, 0.0375% SDS, 
and 20% methanol), and the blots were incubated for 1 h in blocking 
buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.05% Tween 20, and 5% 
nonfat milk). Blots were incubated overnight at 4°C in TBS-T (50 mM Tris, 
pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 10% block-
ing buffer and 1:1,000 PCNA (Sigma-Aldrich), GAP-43 (Sigma-Aldrich), 
neuroﬁ  lament (for PC12; 2H3; Developmental Studies Hybridoma Bank), 
  neuroﬁ  lament-M (for Nt2-D1; Cell Signaling), or β-actin (SC-1615; Santa 
Cruz Biotechnology, Inc.). The neuroﬁ  lament antibody 2H3 was obtained 
from the Developmental Studies Hybridoma Bank developed under the aus-
pices of the National Institute of Child Health and Human Development 
and maintained by the Department of Biological Sciences at the University 
of Iowa. The blots were washed in TBS-T. After incubation with the appro-
priate secondary antibody and extensive washing in TBS-T, the blots were 
developed by ECL.
After ﬁ  xation, the cells were treated with PBS + 0.1% Triton X-100 
for 5 min and subsequently blocked with PBS containing 5% normal goat 
serum. After blocking, the cells were incubated with 1:100 MT antibody 
(Cell Signaling) in PBS + 3% BSA and afterward incubated with 1:5,000 
anti–rabbit Cy3. After the ﬁ  rst staining, the cells were stained for neuroﬁ  la-
ment (2H3; Developmental Studies Hybridoma Bank) identical to the MT 
staining but with anti–mouse Cy5 as a secondary antibody. The cells were 
washed three times in PBS between every step. After staining, the glass cov-
erslips were mounted in moviol. Immunoﬂ  uorescently labeled cells were an-
alyzed using confocal laser scanning microscopy at ambient temperature.
Rabbit immunization and serum preparation
GST-tagged d-Asb11 was puriﬁ  ed  from  Escherichia coli BL21 bacteria 
  using glutathione–Sepharose beads. Rabbits were immunized with GST-
tagged d-Asb11. Subsequently, the serum containing the polyclonal 
antibody directed against d-Asb11 was used in immunoblotting analysis.
Zebraﬁ  sh cell lysates for immunoblotting
Embryos were lysed in cell lysis buffer (50 mM Hepes, pH 7.5, 150 mM 
NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, and 1% Triton X-100) 
at 4°C (7.5–12.5 μl/embryo). Loading buffer was added to the cell lysis 
buffer, and samples were boiled for 3 min. A total equivalent of ﬁ  ve em-
bryos was loaded per lane.
Online supplemental material
Supplemental material provides information about the identiﬁ  cation  of 
d-Asb11 and testing of d-asb11 morphants. Fig. S1 presents the charac-
terization of d-Asb11 and the Asb subfamily of proteins. Fig. S2 shows 
the generation of a d-Asb11 antibody and validation of d-Asb11 expres-
sion during embryogenesis. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200601081/DC1.
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